Welcome to LookChem.com Sign In|Join Free
  • or
N-(4-tert-butyl)benzyl thiourea is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

134232-41-0

Post Buying Request

134232-41-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

134232-41-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 134232-41-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,2,3 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 134232-41:
(8*1)+(7*3)+(6*4)+(5*2)+(4*3)+(3*2)+(2*4)+(1*1)=90
90 % 10 = 0
So 134232-41-0 is a valid CAS Registry Number.

134232-41-0Downstream Products

134232-41-0Relevant academic research and scientific papers

Reductive alkylation of thioureas: A highly practical synthesis of unsymmetrical N,N′-disubstituted thioureas

Ciszewski, Lech,Xu, Daquiang,Repi?, Oljan,Blacklock, Thomas J.

, p. 8091 - 8093 (2007/10/03)

A highly practical synthesis of unsymmetrical N,N′-disubstituted thioureas by the reductive alkylation of N-monosubstituted thioureas with aldehydes is described. N-Monosubstituted thioureas can in turn be synthesized by the reductive amination of thiourea with an appropriate aldehyde. This reductive alkylation methodology was also extended to carbamates.

Novel thiourea derivatives and the pharmaceutical compositions containing the same

-

, (2008/06/13)

The present invention relates to novel thiourca derivatives as a modulator for vanilloid receptor (VR) and the phar- maceutical compositions containing the same. As diseases associated with the activity of vanilloid receptor, pain acute pain, chronic pain, neuropathic pain, post-operative pain, migraine, arthralgia, neuropathies, nerve injury, diabetic neuropathy, neurodegeneration, neurotic skin disorder, stroke, urinary bladder hypersensitiveness, irritable bowel syndrome, a respiratory disorder such as asthma or chronic obstructive pulmonary disease, irritation of skin, eye or mucous membrane, fervescence, stomach-duodenal ulcer, inflam- matory bowel disease and inflammatory diseases can be enumerated. The present invention provides a pharmaceutical composition for prevention or treatment of these diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 134232-41-0